Healthcare >> CEO Interviews >> July 5, 2004


THOMAS V. GEIMER has been the Chairman of the Board of Directors and a Director of Accelr8 Technology Corporation since 1987. He currently serves as the Chief Executive Officer, Chief Financial Officer and Secretary of the company. Mr. Geimer is responsible for the development of the company's business strategy, day-to-day operations, accounting and finance functions. Before assuming full-time responsibilities at the company, Mr. Geimer founded and operated an investment banking firm. Profile
DAVID HOWSON joined Accelr8 Technology Corporation in 2001 and became President in 2004. Originally he was Accelr8's Director of Bioscience Business Development. As President, Mr. Howson is responsible for the management of operations, product development, and regulatory approval oversight. Before assuming responsibilities at the company, Mr. Howson founded and operated the Altro Group, LLC, a medical technology consulting firm. Over the last 30 years, Mr. Howson has consulted to Pfizer, Becton Dickinson & Co. and Boston Scientific in the area of medical technology and new product development. Profile
TWST: Give us a brief history of Accelr8 Technology Corporation and tell

us what you have been doing lately.

Mr. Geimer: As you probably know, we've been public since 1987, and for

the first